featured
Management of Immune-Related Adverse Events in Patients Treated With CAR T-Cell Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline
J. Clin. Oncol 2021 Dec 10;39(35)3978-3992, BD Santomasso, LJ Nastoupil, S Adkins, C Lacchetti, BJ Schneider, M Anadkat, MB Atkins, KJ Brassil, JM Caterino, I Chau, MJ Davies, MS Ernstoff, L Fecher, P Funchain, I Jaiyesimi, JS Mammen, J Naidoo, A Naing, T Phillips, LD Porter, CA Reichner, C Seigel, JM Song, A Spira, M Suarez-Almazor, U Swami, JA Thompson, P Vikas, Y Wang, JS Weber, K Bollin, M GhoshFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.